Bionano Genomics, Inc. — Director's Dealing 2018

Aug 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioNano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2018-08-23

Reporting Person: DP VIII Associates, L.P. (10% Owner)
Reporting Person: BLAIR JAMES C (10% Owner)
Reporting Person: DOVEY BRIAN H (10% Owner)
Reporting Person: TREU JESSE I (10% Owner)
Reporting Person: VITULLO NICOLE (10% Owner)
Reporting Person: Halak Brian K (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-23	Common Stock	C	4386	—	Acquired	4386	Direct
2018-08-23	Common Stock	C	2505	$4.59	Acquired	6891	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-23	Series B Preferred Stock	$	C	50532	Disposed		Common Stock (1180)	Direct
2018-08-23	Series B-1 Preferred Stock	$	C	22161	Disposed		Common Stock (518)	Direct
2018-08-23	Series C Preferred Stock	$	C	40268	Disposed		Common Stock (941)	Direct
2018-08-23	Series D Preferred Stock	$	C	47460	Disposed		Common Stock (1109)	Direct
2018-08-23	Series D-1 Preferred Stock	$	C	27328	Disposed		Common Stock (638)	Direct
2018-08-23	Convertible Promissory Note	$4.59	C		Disposed		Common Stock (2505)	Direct

Footnotes

F1: All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The Preferred Stock had no expiration date

F2: The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.

F3: The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $11,048. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the "Conversion Amount") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share.